About me
Dr. Amalia Capilla is CEO of Miramoon Pharma and a biotech executive with 20+ years of experience in regenerative medicine, gene and cell therapy, and translational research. She holds a PhD in Molecular Biology from the University of Valencia and completed postdoctoral training at UC San Diego and Boston University. She currently leads Miramoon Pharma’s mission to develop innovative therapies for rare and neurodegenerative diseases.
